Covered recipient · General Payments record
CASEY LAYNE GREGOIRE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2019–2023
$2,269.61
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $469.07 | 11 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $200.10 | 5 |
| Janssen Pharmaceuticals, Inc | $132.64 | 2 |
| Indivior Inc. | $57.90 | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $56.67 | 1 |
| BioXcel Therapeutics, Inc. | $21.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $20.12 | 02/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022826543 | CMS |
| Alkermes, Inc. | $24.70 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022826545 | CMS |
| Alkermes, Inc. | $16.59 | 04/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022826547 | CMS |
| Alkermes, Inc. | $23.13 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022826549 | CMS |
| Alkermes, Inc. | $115.56 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022826551 | CMS |
| BioXcel Therapeutics, Inc. | $21.76 | 01/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057513089 | CMS |
| Indivior Inc. | $28.40 | 02/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034230385 | CMS |
| Indivior Inc. | $29.50 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1034230393 | CMS |
| Janssen Pharmaceuticals, Inc | $112.63 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988598455 | CMS |
| Janssen Pharmaceuticals, Inc | $20.01 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988598451 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $56.67 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014019245 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.